工程化二甲基德克斯/四元化奇托桑水凝,包含米瑞胺纳米颗粒,用于糖尿病口腔伤口管理
Xiaoqian Du1, Huijie Zhang2, Bo Li3
1Department of Nursing, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China.
Colloids and surfaces. B, Biointerfaces
|January 10, 2026
概括
一种新的可注射水凝,DQM1,通过对抗微生物和炎症,促进糖尿病口腔的愈合. 这种生物降解材料加速组织再生,为糖尿病口腔伤口提供了有前途的解决方案.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 口腔健康 口腔健康
背景情况:
- 糖尿病口腔由于微生物问题,氧化应激和血管化不良而表现出不良的愈合.
- 目前用于糖尿病口腔伤口的治疗方法的有效性有限.
研究的目的:
- 开发和评估DQM1,一种可注射的水凝生物材料,用于增强糖尿病口腔伤口再生.
- 评估DQM1创造有利治愈环境的能力.
主要方法:
- DQM1水凝由二甲基德克斯和四级化奇托与米瑞纳米颗粒合成.
- 使用实验室模型和动物实验对象进行体外和体内研究,以评估愈合疗效.
- 对抗微生物活性,反应性氧物种清除和生物降解性的评估.
主要成果:
- 在注射后,DQM1形成了一种保护性屏障,具有抗微生物和抗氧化特性.
- 水凝有效地将伤口环境从炎症转移到再生.
- 在临床前模型中观察到口腔粘膜伤口愈合的显著加速.
结论:
- DQM1水凝显示出治疗糖尿病口腔病变的巨大潜力.
- 生物降解性质确保了安全性和有效性.
- 这种创新的治疗平台为患有糖尿病口腔并发症的患者提供了改善的预后.
相关概念视频
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
175
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
175
01:28Diabetic Nephropathy
52
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
52